{{htmlmetatags>
  metatag-keywords=(Syndromes Geriatriques, Neurocognitif, Alzheimer, COVID19, Facteur de Risque, Mortalité, 2021-03)

  metatag-og:title=(COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US. Wang Q, et al, Alzheimers Dement 2021.)

  metatag-description=(COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US. Wang Q, et al, Alzheimers Dement 2021.)

  metatag-og:type=article
  metatag-article:published_time=2021-03-02
  metatag-article:modified_time=2023-05-20

}}
{{page>:priv:keywords&nofooter&noeditbtn}}
~~NOTOC~~

<grid>
<col xs="12" sm="1" md="1" lg="1">
</col>
<col xs="12" sm="10" md="10" lg="10">

{{pmid>addtt:33559975|COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US.}}
{{pmid>addhash_fr:33559975|Syndromes_Geriatriques, Alzheimer, COVID19, Facteur_de_Risque, Mortalité}}

====== COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US. Wang Q, et al, Alzheimers Dement 2021. ======

<callout type="success">
{{tag>Syndromes_Geriatriques Neurocognitif   }}
{{tag>Alzheimer, COVID19, Facteur_de_Risque, Mortalité}}
</callout>

<callout type="warning">
  * **Proposé le :** 02/03/2021 08:07:04
  * **Par :** [[:user:tweetuser]]
  * **Avec la version du site :** <label type="warning">**v2021_01_12**</label>
  * **Revu par :** 
    * //Mettre votre nom d'utilisateur//
    * //Mettre votre nom d'utilisateur//

{{tag>Proposé_à_relecture 2021-03 Non_attribué Non_finalisé}}
</callout>

{{page>:veille:info:part_authors_instructions&noindent&nolink&nofooter&noeditbtn}}

===== Résumé et points clés =====



**Introduction:** At present, there is limited data on the risks, disparity, and outcomes for COVID-19 in patients with dementia in the United States.

**Methods:** This is a retrospective case-control analysis of patient electronic health records (EHRs) of 61.9 million adult and senior patients (age ≥ 18 years) in the United States up to August 21, 2020.

**Results:** Patients with dementia were at increased risk for COVID-19 compared to patients without dementia (adjusted odds ratio [AOR]: 2.00 [95% confidence interval (CI), 1.94-2.06], P < .001), with the strongest effect for vascular dementia (AOR: 3.17 [95% CI, 2.97-3.37], P < .001), followed by presenile dementia (AOR: 2.62 [95% CI, 2.28-3.00], P < .001), Alzheimer's disease (AOR: 1.86 [95% CI, 1.77-1.96], P < .001), senile dementia (AOR: 1.99 [95% CI, 1.86-2.13], P < .001) and post-traumatic dementia (AOR: 1.67 [95% CI, 1.51-1.86] P < .001). Blacks with dementia had higher risk of COVID-19 than Whites (AOR: 2.86 [95% CI, 2.67-3.06], P < .001). The 6-month mortality and hospitalization risks in patients with dementia and COVID-19 were 20.99% and 59.26%, respectively. 

**Discussion:** These findings highlight the need to protect patients with dementia as part of the strategy to control the COVID-19 pandemic.

===== Références de l'article =====

{{pmid>listgroup:33559975}}

----

{{page>:veille:pm:discussion:33559975&nofooter&nolink&noindent}}


<btn type="primary">[[:veille:pm:discussion:33559975?do=edit|Éditer la discussion]]</btn>


----

===== Références =====

~~REFNOTES~~

</col>
<col xs="12" sm="1" md="1" lg="1">
</col>
</grid>

{{page>:start_news:start_newsletter&noident&nofooter&noeditbtn}}